Biomarker Testing for Cancer Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biomarker Testing for Cancer
1.2 Key Market Segments
1.2.1 Biomarker Testing for Cancer Segment by Type
1.2.2 Biomarker Testing for Cancer Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biomarker Testing for Cancer Market Overview
2.1 Global Market Overview
2.1.1 Global Biomarker Testing for Cancer Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biomarker Testing for Cancer Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biomarker Testing for Cancer Market Competitive Landscape
3.1 Global Biomarker Testing for Cancer Sales by Manufacturers (2019-2024)
3.2 Global Biomarker Testing for Cancer Revenue Market Share by Manufacturers (2019-2024)
3.3 Biomarker Testing for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biomarker Testing for Cancer Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biomarker Testing for Cancer Sales Sites, Area Served, Product Type
3.6 Biomarker Testing for Cancer Market Competitive Situation and Trends
3.6.1 Biomarker Testing for Cancer Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biomarker Testing for Cancer Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biomarker Testing for Cancer Industry Chain Analysis
4.1 Biomarker Testing for Cancer Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biomarker Testing for Cancer Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biomarker Testing for Cancer Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biomarker Testing for Cancer Sales Market Share by Type (2019-2024)
6.3 Global Biomarker Testing for Cancer Market Size Market Share by Type (2019-2024)
6.4 Global Biomarker Testing for Cancer Price by Type (2019-2024)
7 Biomarker Testing for Cancer Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biomarker Testing for Cancer Market Sales by Application (2019-2024)
7.3 Global Biomarker Testing for Cancer Market Size (M USD) by Application (2019-2024)
7.4 Global Biomarker Testing for Cancer Sales Growth Rate by Application (2019-2024)
8 Biomarker Testing for Cancer Market Segmentation by Region
8.1 Global Biomarker Testing for Cancer Sales by Region
8.1.1 Global Biomarker Testing for Cancer Sales by Region
8.1.2 Global Biomarker Testing for Cancer Sales Market Share by Region
8.2 North America
8.2.1 North America Biomarker Testing for Cancer Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biomarker Testing for Cancer Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biomarker Testing for Cancer Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biomarker Testing for Cancer Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biomarker Testing for Cancer Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 F. Hoffmann-L A Roche
9.1.1 F. Hoffmann-L A Roche Biomarker Testing for Cancer Basic Information
9.1.2 F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Overview
9.1.3 F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Market Performance
9.1.4 F. Hoffmann-L A Roche Business Overview
9.1.5 F. Hoffmann-L A Roche Biomarker Testing for Cancer SWOT Analysis
9.1.6 F. Hoffmann-L A Roche Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Biomarker Testing for Cancer Basic Information
9.2.2 Thermo Fisher Scientific Biomarker Testing for Cancer Product Overview
9.2.3 Thermo Fisher Scientific Biomarker Testing for Cancer Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Biomarker Testing for Cancer SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 Qiagen N.V.
9.3.1 Qiagen N.V. Biomarker Testing for Cancer Basic Information
9.3.2 Qiagen N.V. Biomarker Testing for Cancer Product Overview
9.3.3 Qiagen N.V. Biomarker Testing for Cancer Product Market Performance
9.3.4 Qiagen N.V. Biomarker Testing for Cancer SWOT Analysis
9.3.5 Qiagen N.V. Business Overview
9.3.6 Qiagen N.V. Recent Developments
9.4 Bio-Rad L aboratories
9.4.1 Bio-Rad L aboratories Biomarker Testing for Cancer Basic Information
9.4.2 Bio-Rad L aboratories Biomarker Testing for Cancer Product Overview
9.4.3 Bio-Rad L aboratories Biomarker Testing for Cancer Product Market Performance
9.4.4 Bio-Rad L aboratories Business Overview
9.4.5 Bio-Rad L aboratories Recent Developments
9.5 llumina
9.5.1 llumina Biomarker Testing for Cancer Basic Information
9.5.2 llumina Biomarker Testing for Cancer Product Overview
9.5.3 llumina Biomarker Testing for Cancer Product Market Performance
9.5.4 llumina Business Overview
9.5.5 llumina Recent Developments
10 Biomarker Testing for Cancer Market Forecast by Region
10.1 Global Biomarker Testing for Cancer Market Size Forecast
10.2 Global Biomarker Testing for Cancer Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biomarker Testing for Cancer Market Size Forecast by Country
10.2.3 Asia Pacific Biomarker Testing for Cancer Market Size Forecast by Region
10.2.4 South America Biomarker Testing for Cancer Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biomarker Testing for Cancer by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biomarker Testing for Cancer Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biomarker Testing for Cancer by Type (2025-2030)
11.1.2 Global Biomarker Testing for Cancer Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biomarker Testing for Cancer by Type (2025-2030)
11.2 Global Biomarker Testing for Cancer Market Forecast by Application (2025-2030)
11.2.1 Global Biomarker Testing for Cancer Sales (K Units) Forecast by Application
11.2.2 Global Biomarker Testing for Cancer Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biomarker Testing for Cancer Market Size Comparison by Region (M USD)
Table 5. Global Biomarker Testing for Cancer Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biomarker Testing for Cancer Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biomarker Testing for Cancer Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biomarker Testing for Cancer Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker Testing for Cancer as of 2022)
Table 10. Global Market Biomarker Testing for Cancer Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biomarker Testing for Cancer Sales Sites and Area Served
Table 12. Manufacturers Biomarker Testing for Cancer Product Type
Table 13. Global Biomarker Testing for Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biomarker Testing for Cancer
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biomarker Testing for Cancer Market Challenges
Table 22. Global Biomarker Testing for Cancer Sales by Type (K Units)
Table 23. Global Biomarker Testing for Cancer Market Size by Type (M USD)
Table 24. Global Biomarker Testing for Cancer Sales (K Units) by Type (2019-2024)
Table 25. Global Biomarker Testing for Cancer Sales Market Share by Type (2019-2024)
Table 26. Global Biomarker Testing for Cancer Market Size (M USD) by Type (2019-2024)
Table 27. Global Biomarker Testing for Cancer Market Size Share by Type (2019-2024)
Table 28. Global Biomarker Testing for Cancer Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biomarker Testing for Cancer Sales (K Units) by Application
Table 30. Global Biomarker Testing for Cancer Market Size by Application
Table 31. Global Biomarker Testing for Cancer Sales by Application (2019-2024) & (K Units)
Table 32. Global Biomarker Testing for Cancer Sales Market Share by Application (2019-2024)
Table 33. Global Biomarker Testing for Cancer Sales by Application (2019-2024) & (M USD)
Table 34. Global Biomarker Testing for Cancer Market Share by Application (2019-2024)
Table 35. Global Biomarker Testing for Cancer Sales Growth Rate by Application (2019-2024)
Table 36. Global Biomarker Testing for Cancer Sales by Region (2019-2024) & (K Units)
Table 37. Global Biomarker Testing for Cancer Sales Market Share by Region (2019-2024)
Table 38. North America Biomarker Testing for Cancer Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biomarker Testing for Cancer Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biomarker Testing for Cancer Sales by Region (2019-2024) & (K Units)
Table 41. South America Biomarker Testing for Cancer Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biomarker Testing for Cancer Sales by Region (2019-2024) & (K Units)
Table 43. F. Hoffmann-L A Roche Biomarker Testing for Cancer Basic Information
Table 44. F. Hoffmann-L A Roche Biomarker Testing for Cancer Product Overview
Table 45. F. Hoffmann-L A Roche Biomarker Testing for Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. F. Hoffmann-L A Roche Business Overview
Table 47. F. Hoffmann-L A Roche Biomarker Testing for Cancer SWOT Analysis
Table 48. F. Hoffmann-L A Roche Recent Developments
Table 49. Thermo Fisher Scientific Biomarker Testing for Cancer Basic Information
Table 50. Thermo Fisher Scientific Biomarker Testing for Cancer Product Overview
Table 51. Thermo Fisher Scientific Biomarker Testing for Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Biomarker Testing for Cancer SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. Qiagen N.V. Biomarker Testing for Cancer Basic Information
Table 56. Qiagen N.V. Biomarker Testing for Cancer Product Overview
Table 57. Qiagen N.V. Biomarker Testing for Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Qiagen N.V. Biomarker Testing for Cancer SWOT Analysis
Table 59. Qiagen N.V. Business Overview
Table 60. Qiagen N.V. Recent Developments
Table 61. Bio-Rad L aboratories Biomarker Testing for Cancer Basic Information
Table 62. Bio-Rad L aboratories Biomarker Testing for Cancer Product Overview
Table 63. Bio-Rad L aboratories Biomarker Testing for Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bio-Rad L aboratories Business Overview
Table 65. Bio-Rad L aboratories Recent Developments
Table 66. llumina Biomarker Testing for Cancer Basic Information
Table 67. llumina Biomarker Testing for Cancer Product Overview
Table 68. llumina Biomarker Testing for Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. llumina Business Overview
Table 70. llumina Recent Developments
Table 71. Global Biomarker Testing for Cancer Sales Forecast by Region (2025-2030) & (K Units)
Table 72. Global Biomarker Testing for Cancer Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Biomarker Testing for Cancer Sales Forecast by Country (2025-2030) & (K Units)
Table 74. North America Biomarker Testing for Cancer Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Biomarker Testing for Cancer Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Biomarker Testing for Cancer Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Biomarker Testing for Cancer Sales Forecast by Region (2025-2030) & (K Units)
Table 78. Asia Pacific Biomarker Testing for Cancer Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Biomarker Testing for Cancer Sales Forecast by Country (2025-2030) & (K Units)
Table 80. South America Biomarker Testing for Cancer Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Biomarker Testing for Cancer Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Biomarker Testing for Cancer Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Biomarker Testing for Cancer Sales Forecast by Type (2025-2030) & (K Units)
Table 84. Global Biomarker Testing for Cancer Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Biomarker Testing for Cancer Price Forecast by Type (2025-2030) & (USD/Unit)
Table 86. Global Biomarker Testing for Cancer Sales (K Units) Forecast by Application (2025-2030)
Table 87. Global Biomarker Testing for Cancer Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biomarker Testing for Cancer
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biomarker Testing for Cancer Market Size (M USD), 2019-2030
Figure 5. Global Biomarker Testing for Cancer Market Size (M USD) (2019-2030)
Figure 6. Global Biomarker Testing for Cancer Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biomarker Testing for Cancer Market Size by Country (M USD)
Figure 11. Biomarker Testing for Cancer Sales Share by Manufacturers in 2023
Figure 12. Global Biomarker Testing for Cancer Revenue Share by Manufacturers in 2023
Figure 13. Biomarker Testing for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biomarker Testing for Cancer Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biomarker Testing for Cancer Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biomarker Testing for Cancer Market Share by Type
Figure 18. Sales Market Share of Biomarker Testing for Cancer by Type (2019-2024)
Figure 19. Sales Market Share of Biomarker Testing for Cancer by Type in 2023
Figure 20. Market Size Share of Biomarker Testing for Cancer by Type (2019-2024)
Figure 21. Market Size Market Share of Biomarker Testing for Cancer by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biomarker Testing for Cancer Market Share by Application
Figure 24. Global Biomarker Testing for Cancer Sales Market Share by Application (2019-2024)
Figure 25. Global Biomarker Testing for Cancer Sales Market Share by Application in 2023
Figure 26. Global Biomarker Testing for Cancer Market Share by Application (2019-2024)
Figure 27. Global Biomarker Testing for Cancer Market Share by Application in 2023
Figure 28. Global Biomarker Testing for Cancer Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biomarker Testing for Cancer Sales Market Share by Region (2019-2024)
Figure 30. North America Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biomarker Testing for Cancer Sales Market Share by Country in 2023
Figure 32. U.S. Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biomarker Testing for Cancer Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biomarker Testing for Cancer Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biomarker Testing for Cancer Sales Market Share by Country in 2023
Figure 37. Germany Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biomarker Testing for Cancer Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biomarker Testing for Cancer Sales Market Share by Region in 2023
Figure 44. China Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biomarker Testing for Cancer Sales and Growth Rate (K Units)
Figure 50. South America Biomarker Testing for Cancer Sales Market Share by Country in 2023
Figure 51. Brazil Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biomarker Testing for Cancer Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biomarker Testing for Cancer Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biomarker Testing for Cancer Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biomarker Testing for Cancer Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biomarker Testing for Cancer Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biomarker Testing for Cancer Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biomarker Testing for Cancer Market Share Forecast by Type (2025-2030)
Figure 65. Global Biomarker Testing for Cancer Sales Forecast by Application (2025-2030)
Figure 66. Global Biomarker Testing for Cancer Market Share Forecast by Application (2025-2030)